MedTrace Logo

Adding Cytokines to In Vitro Human Culture Media to Improve Embryogenesis and Implantation

NCT02420886 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 443

Last updated 2018-10-02

No results posted yet for this study

Summary

Assessment of the embryological benefit of in vitro adding of Cytokines (LIF 5ng/ml, HB-EGF 5ng/ml and GM-CSF 2n/ml) to the culture media and closely monitor its effect on embryogenesis and implantation outcomes.

Conditions

Interventions

OTHER

Adding LIF, HB-EGF and GM-CSF to Lifeglobal human IVF culture media

Sponsors & Collaborators

  • Banon IVF Center Assiut, Egypt

    collaborator OTHER

  • Ibn Sina Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-16
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02420886 on ClinicalTrials.gov